About YorkTest
YorkTest is a Healthcare company based in York (United Kingdom) founded in 1982, and was acquired by Key Capital Partners in July 2017. It operates as an at-home food and allergy test kits are developed by YorkTest. YorkTest has raised $12.03 million across 1 funding round from investors including NVM Private Equity, DDME and Key Capital Partners. Its website yorktest.com draws about 282 thousand monthly visits. YorkTest offers products and services including Premium Food Intolerance Test, Food Allergy Test, and Food Intolerance and Allergy Bundle. Its focus areas include Life Sciences, Immunology, In Vitro Diagnostic Tests and Allergies. Its legal entity is YORKTEST LABORATORIES LIMITED. Its competitors include Allergy Amulet, Microtest Diagnostics, ATANIS Biotech, DST and Immunovent and 3 more; 2 of its 8 listed competitors have raised funding.
Company details
YorkTest is a UK-based, commercialized At-Home consumer diagnostics company developing food allergy and other allergy test kits, based on IgG reaction. The company has multiple tests which can be mail-ordered and the blood sample sent to the lab by a prepaid post. The tests are based sequentially, with an initial Introductory Test, for GBP 25 which gives a positivenegative result. If the Introductory Test is positive, the customer is recommended a second test, such as Food Scan, Food and Drink Scan, IBS Diet, and Ideal Weight tests, which cost between GBP 250 and GBP 320, and test for 113 to 153 ingredients based on the test. While food allergies kits is their main product line, they also have test kits for hay fever environmental allergens, homocysteine, and liver enzyme levels.
- Headquarters York, United Kingdom
- SectorsHealthcare
- Website category Health · Health Conditions and Concerns
- Email••••••••
- Phone•••• ••••
- Website yorktest.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Key Capital Partners (Jul 2017)
- Legal Name Yorktest Laboratories Limited
- Date of Incorporation 27 May, 1998
- Jurisdiction YORK, ENGLAND
- Total Equity Funding$12.03M (USD)
in 1 rounds
- Latest Funding Round$12.03M (USD), Private Equity Round
Jul 2022
- InvestorsNVM Private Equity
& 2 more
- Acquired by
Products & Services of YorkTest
YorkTest offers a comprehensive portfolio of products and services, including Premium Food Intolerance Test, Food Allergy Test, and Food Intolerance and Allergy Bundle.
Analyzes reactivity to 200 food ingredients via blood sample.
Detects reactions to common allergens for health management.
Combines intolerance and allergy tests for comprehensive analysis.
Apps and channels of YorkTest
its YouTube channel YorkTest has 370 subscribers and 24 videos.
Videos from YorkTest
The most watched videos on YorkTest's YouTube channel, YorkTest (370 subscribers). Click a video to play it here.
More on YorkTest.
Funding Insights of YorkTest
YorkTest has successfully raised a total of $12.03M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $12.03 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.03M
- Total Rounds 1
- Last Round Private Equity Round — $12.03M
- First Round $12.03M
(Jul 2022)
- Investors Count 1
All 1 funding rounds of YorkTest with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $12.03M | Private Equity Round | – | – |
3 investors in total: 3 institutional.
Investors in YorkTest
YorkTest has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include NVM Private Equity, DDME and Key Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are managed across the UK. | 1984 | nvm.co.uk | Newcastle Upon Tyne, United Kingdom | |
Investment in UK small-cap businesses is provided for growth. | – | keycapitalpartners.co.uk | Leeds, United Kingdom | |
A web design and development agency specializing in Craft CMS. | 2018 | ingemino.com | Halifax, United Kingdom |
Investor details for YorkTest
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of YorkTest
7 people are tracked at YorkTest (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Gemma Callaghan | Chief Commercial Officer (cco) | Leadership |
Sabrina Quinn | Chief Technology Officer | Leadership |
Rob Wilson | Laboratory Director | Leadership |
Richard Dawson | Chief Executive Officer | Leadership |
Sara Sutherland | Laboratory Manager | Team |
Star Freudenberg | Nutritional Therapist & Phlebotomist | Team |
Andrew Meredith | Practitioner Account Executive | Team |
Complete people profiles for YorkTest
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of YorkTest
4 dated milestones of YorkTest across 40 years, from founding to its latest funding, stage changes and deals.
- Founded YorkTest is founded.
- Exit Acquired by Ingemino Ltd.
- Exit Acquired by Key Capital Partners.
- Funding First funding round of $12.0M.
Competitors of YorkTest
YorkTest has 8 listed competitors in our database, 2 of them funded. They include Allergy Amulet, Microtest Diagnostics, ATANIS Biotech, DST and Immunovent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| allergyamulet.com | 2016 | Madison, United States | $12.57M | – | Portable food allergen sensors are offered via an online platform. | |
| microtestdx.com | 2002 | London, United Kingdom | $2.5M | 6 | Functions as an automated allergy testing service. | |
| atanis-biotech.com | 2021 | Sursee, Switzerland | – | – | Developer of a cell-based assay for the diagnosis of allergies | |
| dst-diagnostic.com | 2005 | Schwerin, Germany | – | 42 | Innovative in-vitro diagnostic solutions are developed by DST. | |
| immunovent.com | 2012 | New York, United States | – | – | Diagnostic tests for allergies are developed using mucosal brush samples. | |
| macroarraydx.com.ua | 2016 | Kiev, Ukraine | – | – | Allergen analyzers are provided for in-vitro IgE level determination. | |
| allergenis.com | 2017 | Hatfield, United States | – | – | Develops accurate allergy testing solutions for healthcare providers and patients. | |
| bangqibio.tcc.mode | 2020 | Suzhou, China | – | – | Instruments and reagents for immune disorder diagnosis are developed. |
Detailed competitors of YorkTest
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of YorkTest
The website of YorkTest (yorktest.com) receives about 281.6K visits a month and ranks #174,910 among all websites worldwide, #5,545 in Health Conditions and Concerns.
- Monthly visits281.6K
▲ 3.8% vs previous month
- Unique visitors124.6K
per month
- Global rank#174,910
among all websites
- Category rank#5,545
Health · Health Conditions and Concerns
- Bounce rate48%
- Pages per visit2.3
- Average visit1 min 32 sec
- DevicesDesktop 18% · Mobile 82%
Websites whose visitors overlap most with YorkTest. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
allergyuk.org | allergyuk.org | 100% | – | #322,525 | – |
cerascreen.co.uk | cerascreen.co.uk | 85% | – | #1,732,309 | – |
foodintol.com | foodintol.com | 79% | – | #6,337,742 | – |
| healthlabs.com | 75% | – | #178,794 | View details | |
| forthwithlife.co.uk | 75% | 120.5K | #354,379 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for YorkTest
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
10 companies that operate in the same segment as YorkTest (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Yorktest
Complete news archive for YorkTest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about YorkTest
YorkTest was founded in 1982 and raised its 1st funding round 40 years after it was founded.
YorkTest is headquartered in York, United Kingdom.
YorkTest is a funded company, having raised a total of $12.03M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $12.03M, raised on Jul 2022.
YorkTest is a UK-based, commercialized At-Home consumer diagnostics company developing food allergy and other allergy test kits, based on IgG reaction. The company has multiple tests which can be mail-ordered and the blood sample sent to the lab by a prepaid post. The tests are based sequentially, with an initial Introductory Test, for GBP 25 which gives a positivenegative result. If the Introductory Test is positive, the customer is recommended a second test, such as Food Scan, Food and Drink Scan, IBS Diet, and Ideal Weight tests, which cost between GBP 250 and GBP 320, and test for 113 to 153 ingredients based on the test. While food allergies kits is their main product line, they also have test kits for hay fever environmental allergens, homocysteine, and liver enzyme levels.
YorkTest's top competitors include Allergy Amulet, ATANIS Biotech and DST.
YorkTest offers Premium Food Intolerance Test, Food Allergy Test, and Food Intolerance and Allergy Bundle.
YorkTest has 3 investors. Key investors include NVM Private Equity, DDME, and Key Capital Partners.
YorkTest operates through Yorktest Laboratories Limited.
Yes. YorkTest was acquired by Key Capital Partners in July 2017.
The website of YorkTest receives about 282 thousand visits a month and ranks #174,910 among all websites worldwide.